Geraldine Pannu's Insider Trades & SAST Disclosures
Geraldine Pannu's most recent trade in RBB Bancorp was a trade of 700 Common Stock, No Par Value done . Disclosure was reported to the exchange on May 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Geraldine Pannu.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 700 | 2,900 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 May 2025 | 700 | 0 | - | - | Restricted Stock Units | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Sep 2024 | 31,206 | 31,206 | - | - | Restricted Stock | |
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 800 | 2,200 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 800 | 700 | - | - | Restricted Stock Units | |
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 600 | 0 | - | - | Restricted Stock Units | |
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2024 | 600 | 1,400 (0%) | 0% | 0 | Common Stock, No Par Value | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 101,365 | 101,365 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 23,636 | 0 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jun 2023 | 23,636 | 53,113 | - | - | Common Stock | |
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 800 | 800 (0%) | 0% | 0 | Common Stock, No Par Value | |
| RBB Bancorp | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2023 | 800 | 600 | - | - | Restricted Stock Units | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 30,000 | 30,000 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 Dec 2022 | 18,208 | 29,477 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 1,169 | 11,269 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 4,393 | 10,100 | - | - | Common Stock | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Mar 2022 | 18,208 | 19,377 | - | - | Restricted Stock | |
| Processa Pharmaceuticals Inc | Geraldine Pannu | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Aug 2021 | 1,169 | 5,707 | - | - | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges